Astrana Health (NASDAQ:ASTH) Shares Gap Down – Time to Sell?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) gapped down prior to trading on Tuesday . The stock had previously closed at $27.22, but opened at $25.41. Astrana Health shares last traded at $21.9770, with a volume of 307,490 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on ASTH. Needham & Company LLC started coverage on shares of Astrana Health in a report on Friday, December 12th. They set a “buy” rating and a $28.00 price target for the company. Barclays dropped their target price on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a report on Monday, November 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. TD Cowen dropped their price objective on Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a report on Monday, November 10th. Finally, BTIG Research cut their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $41.33.

Astrana Health Price Performance

The firm’s 50 day moving average is $24.55 and its 200 day moving average is $26.96. The firm has a market cap of $1.21 billion, a P/E ratio of 113.27, a price-to-earnings-growth ratio of 0.68 and a beta of 0.87. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.40 and a quick ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The company had revenue of $956.05 million during the quarter, compared to the consensus estimate of $952.83 million. During the same period in the prior year, the firm earned $0.33 earnings per share. The business’s revenue for the quarter was up 99.7% compared to the same quarter last year. As a group, analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

A number of hedge funds have recently bought and sold shares of ASTH. Signaturefd LLC raised its holdings in Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares in the last quarter. Covestor Ltd raised its holdings in Astrana Health by 210.6% in the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after acquiring an additional 2,192 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares in the last quarter. Finally, State of Wyoming bought a new position in Astrana Health in the 2nd quarter valued at approximately $132,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.